ClearPoint Neuro (CLPT) Competitors $11.40 -0.56 (-4.68%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$11.32 -0.08 (-0.66%) As of 07/11/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLPT vs. ESTA, TNDM, FNA, BLFS, LQDA, SSII, PLSE, INMD, MDXG, and KMTSShould you be buying ClearPoint Neuro stock or one of its competitors? The main competitors of ClearPoint Neuro include Establishment Labs (ESTA), Tandem Diabetes Care (TNDM), Paragon 28 (FNA), BioLife Solutions (BLFS), Liquidia Technologies (LQDA), SS Innovations International (SSII), Pulse Biosciences (PLSE), InMode (INMD), MiMedx Group (MDXG), and Kestra Medical Technologies (KMTS). These companies are all part of the "medical equipment" industry. ClearPoint Neuro vs. Its Competitors Establishment Labs Tandem Diabetes Care Paragon 28 BioLife Solutions Liquidia Technologies SS Innovations International Pulse Biosciences InMode MiMedx Group Kestra Medical Technologies ClearPoint Neuro (NASDAQ:CLPT) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership. Is CLPT or ESTA more profitable? Establishment Labs has a net margin of -52.34% compared to ClearPoint Neuro's net margin of -64.51%. ClearPoint Neuro's return on equity of -78.09% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets ClearPoint Neuro-64.51% -78.09% -51.33% Establishment Labs -52.34%-196.25%-26.64% Do insiders & institutionals have more ownership in CLPT or ESTA? 30.1% of ClearPoint Neuro shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 7.0% of ClearPoint Neuro shares are owned by company insiders. Comparatively, 11.1% of Establishment Labs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to CLPT or ESTA? In the previous week, Establishment Labs had 3 more articles in the media than ClearPoint Neuro. MarketBeat recorded 7 mentions for Establishment Labs and 4 mentions for ClearPoint Neuro. Establishment Labs' average media sentiment score of 1.19 beat ClearPoint Neuro's score of 0.62 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ClearPoint Neuro 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Establishment Labs 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, CLPT or ESTA? ClearPoint Neuro has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Which has preferable valuation & earnings, CLPT or ESTA? ClearPoint Neuro has higher earnings, but lower revenue than Establishment Labs. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearPoint Neuro$31.39M10.17-$18.91M-$0.76-15.00Establishment Labs$166.02M7.82-$84.60M-$3.10-14.48 Do analysts prefer CLPT or ESTA? ClearPoint Neuro currently has a consensus price target of $25.00, suggesting a potential upside of 119.30%. Establishment Labs has a consensus price target of $51.80, suggesting a potential upside of 15.39%. Given ClearPoint Neuro's stronger consensus rating and higher probable upside, equities research analysts plainly believe ClearPoint Neuro is more favorable than Establishment Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ClearPoint Neuro 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 SummaryEstablishment Labs beats ClearPoint Neuro on 9 of the 16 factors compared between the two stocks. Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLPT vs. The Competition Export to ExcelMetricClearPoint NeuroMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$334.75M$6.82B$5.61B$9.11BDividend YieldN/A1.25%5.24%4.01%P/E Ratio-15.0024.8927.9620.25Price / Sales10.1765.26430.8999.65Price / CashN/A20.9237.4658.16Price / Book12.394.648.045.49Net Income-$18.91M$174.76M$3.18B$250.27M7 Day Performance-3.80%-1.00%3.68%4.80%1 Month Performance-5.63%-1.49%4.10%7.68%1 Year Performance51.60%4.27%29.59%16.36% ClearPoint Neuro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLPTClearPoint Neuro1.7227 of 5 stars$11.40-4.7%$25.00+119.3%+48.8%$334.75M$31.39M-15.00110News CoverageAnalyst DowngradeESTAEstablishment Labs1.5274 of 5 stars$46.11+5.9%$52.40+13.6%-1.6%$1.26B$166.02M-14.871,018Analyst ForecastTNDMTandem Diabetes Care4.1176 of 5 stars$16.25-3.2%$33.43+105.7%-65.5%$1.12B$940.20M-5.852,650Positive NewsAnalyst ForecastFNAParagon 28N/A$13.11+0.1%$12.75-2.7%+72.9%$1.10B$256.18M-17.71343,000High Trading VolumeBLFSBioLife Solutions2.1511 of 5 stars$21.81-4.5%$31.17+42.9%+4.7%$1.08B$82.25M-75.20440Positive NewsLQDALiquidia Technologies3.1492 of 5 stars$12.45+2.1%$26.89+116.0%+13.0%$1.04B$14M-7.8850SSIISS Innovations InternationalN/A$5.27-1.3%N/AN/A$1.03B$20.65M0.004News CoverageGap UpPLSEPulse Biosciences3.8549 of 5 stars$15.81+3.3%$22.00+39.2%-0.6%$1.03B$700K0.00140INMDInMode4.0056 of 5 stars$15.10-0.4%$18.54+22.8%-12.5%$958.25M$394.82M6.48480News CoveragePositive NewsAnalyst ForecastMDXGMiMedx Group3.6984 of 5 stars$6.48+2.2%$12.50+92.9%-6.3%$936.43M$348.88M24.00870News CoverageKMTSKestra Medical TechnologiesN/A$14.75-5.9%$27.50+86.4%N/A$804.63MN/A0.00300 Related Companies and Tools Related Companies Establishment Labs Competitors Tandem Diabetes Care Competitors Paragon 28 Competitors BioLife Solutions Competitors Liquidia Technologies Competitors SS Innovations International Competitors Pulse Biosciences Competitors InMode Competitors MiMedx Group Competitors Kestra Medical Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLPT) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored"I'm risking my reputation on this"Most people think you need thousands to profit from crypto. But this free book exposes how even small inves...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
